entity

SMPD3

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SMPD3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

0Connections
2Hypotheses
0Analyses
0Outgoing
0Incoming

Wiki Pages (1)

Knowledge base pages for this entity

Sphingolipid Metabolism in Neurodegeneration

mechanisms · 3241 words

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Selective Neutral Sphingomyelinase-2 Inhibition Therapy 0.591 neurodegeneration Lipid raft composition changes in synapt
Neutral Sphingomyelinase-2 Inhibition for Synaptic Protectio 0.546 neurodegeneration Lipid raft composition changes in synapt

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found